# Vensana Capital

Vensana Capital is a Private Equity based in Edina, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Edina, United States
- **Region:** North America
- **Address:** Minneapolis, MN, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** vensanacap.com
- **LinkedIn:** https://www.linkedin.com/company/vensana-capital

## Regulatory record

- **CRD number:** 300695
- **SEC file number:** 802-114814
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/300695

## About

Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology. It actively invests in development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services.

## Sectors

- Digital Health
- MedTech

## People

- Justin Klein — Managing Partner
- Kirk Nielsen — Managing Partner

## Questions

### Who runs investment decisions at Vensana Capital?

Managing Partners Justin Klein and Kirk Nielsen jointly lead the investment committee. Both have deep operating and investing backgrounds in medical technology. All investment decisions are made internally by the partnership.

### What differentiates Vensana's medtech focus from generalist healthcare funds?

Vensana restricts its mandate to regulated medical devices, diagnostics, and data-enabled therapeutic technologies — it does not invest in biotech, healthcare services, or digital health platforms that lack a physical medical device component. This specialization gives the firm's team focused clinical and regulatory expertise that generalist funds rarely develop.

### Which investment stages does Vensana Capital target?

The firm invests from early-stage venture rounds through late-stage growth equity, covering pre-commercial, clinical-trial-stage, and revenue-stage companies. This broad stage mandate allows Vensana to support portfolio companies across their entire development lifecycle.

### Does Vensana Capital participate in fund commitments or only direct deals?

Vensana deploys capital primarily through direct equity investments and co-investments. There is no public indication that the firm allocates to third-party funds as a limited partner.

### Which sectors does Vensana Capital explicitly avoid?

The firm does not invest in traditional biotechnology, pharmaceutical development, or pure healthcare services. Its mandate specifically excludes therapeutic areas that do not involve a regulated medical device or diagnostic platform.

## Related profiles

- [Venrock Healthcare Capital Partners](https://altss.com/profile/venrock-healthcare-capital-partners)
- [Venstar Investments](https://altss.com/profile/venstar-investments)

---

Last updated: 2026-08-11T15:08:22.057Z

Canonical page: https://altss.com/profile/vensana-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology